ODDB.org: Open Drug Database

Roche Pharma (Schweiz) AG - TECENTRIQ subkutan 1875 mg/15ml, Injektionslösung zur subkutanen Anwendung

Swissmedic Registration	69262	Sequence	01
Product name	TECENTRIQ subkutan 1875 mg/15ml	Description	Injektionslösung zur subkutanen Anwendung
ATC-Classification	L01FF05	ATC-Description
Introduction of Sequence	05.08.2024

Composition

atezolizumabum 1875 mg, hyaluronidasum humanum ADNr, histidinum, acidum aceticum 30 per centum, saccharum, polysorbatum 20, methioninum, aqua ad iniectabile ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Injektionslösung zur subkutanen Anwendung

Excipiens

Active Agent	Dose
Atezolizumabum	1875mg / 15ml

BAG: Active Agent	Dose
Atezolizumabum	1875 mg

Inactive agents	Dose
Acetic Acid	30
Histidine
Hyaluronidasum Humanum Adnr
Methionine
Per Centum
Polysorbatum 20
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		4370.35	4769.45	A	SL	No

2025	©ywesee GmbH